Biotech Environment in 2016: Reverse Engineering the Ecosystem #BES2016
BIO-Europe Spring 2016 is starting off right away with the plenary opening session. The conference…
April 4, 2016 - 5 minutes
AstraZeneca
New UK Joint Venture Bridges Gap between Top Universities and Big Pharmas
AstraZeneca, GlaxoSmithKline, Johnson & Johnson and the 3 world-leading universities (Imperial College London, University College…
January 27, 2016 - 3 minutes
A French Biotech is Monopolising Immuno-Oncology with Big Euro Deals
Marseille's Innate Pharma is building an Immuno-Oncology Monopoly, deal by deal. Selling to the French…
January 11, 2016 - 3 minutes
How about the $100M Holy ‘GRAIL’ in Cancer Diagnostics? A Universal Test Start-up Faces German Competition
Illumina, the €22Bn Market cap NGS specialist, and Bill Gates pooled a $100M to fund…
January 11, 2016 - 3 minutes
Mystery Biotech No One has Ever Heard of in Biggest Deal of the Year for $7Bn
Acerta Pharma is an elusive Netherlands based Biotech with pipelines in Blood cancer and solid…
December 21, 2015 - 3 minutes
Genentech’s Sean Bohen defects to AstraZeneca as CMO
AstraZeneca's Senior management team gets reinforced by Sean Bohen, a top executive from Roche's subsidiary…
September 1, 2015 - 2 minutes
A $500 Million Deal to Reactivate T-cells’ Anti-cancer Response
Heptares Therapeutics, the GPCR-targeted drug company, and British pharma giant AstraZeneca entered a new collaboration…
August 10, 2015 - 2 minutes
AstraZeneca Adds New Antisense Drugs to its Pipeline
Isis Pharmaceuticals and AstraZeneca extend their collaboration to discover and develop antisense therapies. After cancer,…
August 5, 2015 - 2 minutes
Struggling AstraZeneca sells Rare Disease drug to Genzyme-Sanofi for €300M
The Pharma giant AstraZeneca is still struggling even if in better shape. It just sold…
July 28, 2015 - 2 minutes
AstraZeneca and Eli Lilly Combine their Innovative Drugs for Cancer Treatment
The big pharma companies Eli Lilly and AstraZeneca will combine two of their cancer drugs…
May 31, 2015 - 2 minutes
Orca Pharmaceuticas Associates with AstraZeneca to Identify Best-in-Class RORγ Inhibitors
Orca Pharmaceuticals, and AstraZeneca embarked on a three year collaboration to develop inhibitors of retinoic…
February 27, 2015 - 2 minutes
New Collaboration for New Cancer Therapies
Medimmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca, has entered…
September 30, 2014 - 2 minutes
